Track the 질경이 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 질경이 has published 13 reports. Market capitalisation: €30.9bn. The latest transaction was filed on 28 May 2026 (Sale). Among the most active insiders: 최원석. All data is accessible without an account.
11
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
5 ops.
Sell Volume
Fundamental score
Ranked 7,104 of 29,212 companies
64.4
score / 100
Value
54
Quality
75
FCF yld-5.3%
Earn yld11%
EV/EBITDA11.7x
ROE·
Gross mgn75%
Net mgn27%
Debt/EBITDA2.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
질경이 is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on the development and marketing of health-related products.